Armistice Capital, LLC Increases Stake in Bicycle Therapeutics plc to 6.75%

Armistice Capital, LLC and its managing member, Steven Boyd, filed a Schedule 13G/A on May 15, 2026, disclosing a significant increase in their position in Bicycle Therapeutics plc (BCYC). As of March 31, 2026, the reporting persons beneficially own 3,398,000 American Depositary Shares, representing approximately 6.75% of the company's outstanding shares. This marks a notable increase from their previously reported 0.0% ownership position. The shares are held directly by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company. Armistice Capital, LLC serves as the investment manager for the Master Fund and exercises shared voting and dispositive power over the securities. Steven Boyd, in his capacity as the managing member of Armistice Capital, may also be deemed to beneficially own these shares. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer.